Headlands Technologies »

Allogene Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $174k 140k 1.24
2024-03-31 $78k 17k 4.47

More positions owned by Headlands Technologies

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Robinhood Mkts Com Cl A (HOOD)
Alphabet Cap Stk Cl A (GOOGL)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Wal-Mart Stores (WMT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ross Stores (ROST)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Honeywell International (HON)
Freeport-mcmoran CL B (FCX)

View all positions for Headlands Technologies

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics